We are live on
!
Find out more
TCM
Tran Capital Management Portfolio holdings
AUM
$869M
1-Year Est. Return
52.91%
This Fund
S&P 500
This Quarter
Est. Return
+3.22%
1 Year Est. Return
+52.91%
3 Year Est. Return
+148.95%
5 Year Est. Return
+156.56%
10 Year Est. Return
+751.84%
AUM
$809M
AUM Growth
+$5.98M
(+0.75%)
Cap. Flow
-$7.84M
Cap. Flow
% of AUM
-0.97%
Top 10 Holdings %
Top 10 Hldgs %
42.33%
Holding
67
New
6
Increased
10
Reduced
30
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FISV
Fiserv Inc
FISV
|
+$31.1M |
| 2 |
Clarivate
CLVT
|
+$29.3M |
| 3 |
Elanco Animal Health
ELAN
|
+$20.1M |
| 4 |
Ball Corp
BALL
|
+$17.8M |
| 5 |
PTC
PTC
|
+$17.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FDC
First Data Corporation
FDC
|
+$32.4M |
| 2 |
Autodesk
ADSK
|
+$19.8M |
| 3 |
SLB Ltd
SLB
|
+$13.8M |
| 4 |
Gilead Sciences
GILD
|
+$12.8M |
| 5 |
Visa
V
|
+$11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Healthcare | 14.48% |
| 3 | Financials | 13.51% |
| 4 | Industrials | 12.27% |
| 5 | Consumer Discretionary | 11.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Verisk Analytics
VRSK
$25.1B
| $474K | 0.06% |
3,000
| – | – |
|
52
Bio-Techne
TECH
$11.2B
| $411K | 0.05% |
8,400
| – | – |
|
53
Bristol-Myers Squibb
BMY
$134B
| $396K | 0.05% |
7,800
| – | – |
|
54
Accenture
ACN
$101B
| $381K | 0.05% |
1,981
| – | – |
|
55
Gentex
GNTX
$4.99B
| $330K | 0.04% |
12,000
-5,000
| -29% | -$132K |
|
56
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $267K | 0.03% |
7,115
| – | – |
|
57
Moody's
MCO
$83.7B
| $205K | 0.03% |
1,000
-1,300
| -57% | -$272K |
|
|
VRAY
58
DELISTED
ViewRay, Inc.
VRAY
| $87K | 0.01% |
30,000
+17,000
| +131% | +$101K |
|
59
Teekay Tankers
TNK
$2.79B
| $26K | ﹤0.01% |
2,500
| – | – |
|
60
Advance Auto Parts
AAP
$3.36B
| – | – |
-2,632
| Closed | -$406K |
|
61
American Vanguard Corp
AVD
$70.4M
| – | – |
-10,600
| Closed | -$163K |
|
62
Canadian Pacific Kansas City
CP
$79.7B
| – | – |
-7,230
| Closed | -$340K |
|
63
Dollar General
DG
$28.2B
| – | – |
-5,032
| Closed | -$680K |
|
|
64
Gilead Sciences
GILD
$163B
| – | – |
-188,950
| Closed | -$12.8M |
|
65
Sabre
SABR
$779M
| – | – |
-10,262
| Closed | -$228K |
|
|
66
SLB Ltd
SLB
$73.2B
| – | – |
-347,892
| Closed | -$13.8M |
|
|
FDC
67
DELISTED
First Data Corporation
FDC
| – | – |
-1,195,744
| Closed | -$32.4M |
|
Similar funds
ICCFIA
PLFA
HP
RWA
WCM
RWM
EI
NEPWA
Tran Capital Management's Q3 2019 Portfolio in Review
As of Q3 2019, Tran Capital Management held 67 positions worth $809M, up 0.75% from $803M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Tran Capital Management's Q3 2019 filing shows 6 new, 10 increased, 30 reduced and 8 closed positions. Its largest new stake was Fiserv Inc: 304,921 shares worth $31.6M. The largest sale was First Data Corporation, an estimated $32.4M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- Tran Capital Management's largest Q3 2019 buy was Fiserv Inc: 304,921 shares worth $31.6M.
- Tran Capital Management added most to Elanco Animal Health in Q3 2019, an estimated $20.1M increase.
- Tran Capital Management's biggest Q3 2019 reduction was Autodesk, cutting an estimated $19.8M.
- Tran Capital Management fully exited First Data Corporation in Q3 2019, selling an estimated $32.4M.
- Tran Capital Management's ten largest holdings make up 42% of its $809M portfolio in Q3 2019.
- Tran Capital Management opened 6 new positions and closed 8 in Q3 2019.
- Tran Capital Management's portfolio value rose 0.75% quarter-over-quarter to $809M.
Based on Tran Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.